Wnt3A Induces GSK‐3β Phosphorylation and β‐Catenin Accumulation Through RhoA/ROCK

Abstract

In canonical pathway, Wnt3A has been known to stabilize β-catenin through the dissociation between β-catenin and glycogen synthase kinase-3β (GSK-3β) that suppresses the phosphorylation and degradation of β-catenin. In non-canonical signaling pathway, Wnt was known to activate Rho GTPases and to induce cell migration. The cross-talk between canonical and non-canonical pathways by Wnt signaling; however, has not been fully elucidated. Here, we revealed that Wnt3A induces not only the phosphorylation of GSK-3β and accumulation of β-catenin but also RhoA activation in RAW264.7 and HEK293 cells. Notably, sh-RhoA and Tat-C3 abolished both the phosphorylation of GSK-3β and accumulation of β-catenin. Y27632, an inhibitor of Rho-associated coiled coil kinase (ROCK) and si-ROCK inhibited both GSK-3β phosphorylation and β-catenin accumulation. Furthermore, active domain of ROCK directly phosphorylated the purified recombinant GSK-3β in vitro. In addition, Wnt3A-induced cell proliferation and migration, which were inhibited by Tat-C3 and Y27632. Taken together, we propose the cross-talk between canonical and non-canonical signaling pathways of Wnt3A, which induces GSK-3β phosphorylation and β-catenin accumulation through RhoA and ROCK activation. J. Cell. Physiol. 232: 1104-1113, 2017. © 2016 Wiley Periodicals, Inc.

Lysophosphatidic acid receptor 4 regulates osteogenic and adipogenic differentiation of progenitor cells via inactivation of RhoA/ROCK1/β-catenin signaling

“…Rossol‐Allison et al suggested that β‐catenin accumulation and RhoA activation may occur independently because in their study RhoA could not regulate either the stabilization or nuclear translocation of β‐catenin induced by Wnt3A . Oppositely, Kim et al reported that these two pathways are closely linked, that is, RhoA/ROCK1 phosphorylates GSK‐3β (Ser9), and accumulates β‐catenin in response to Wnt3A . Consistent with Kim et al's report, we found that the activation of ROCK1 displayed a stimulatory effect on canonical Wnt signals, leading to the accumulation of phosphorylated LRP6, phosphorylated GSK‐3β (Ser9), active β‐catenin, and TCF7L2.…”

Wnt3a and wnt5a as Potential Chondrogenic Stimulators for Nucleus Pulposus Cell Induction: A Comprehensive Review

“…www.e-neurospine.org 23 reviews reporting contradictory conclusions, stating that wnt3a stimulates, 20 but also inhibits chondrogenic differentiation. 19 Another unusual characteristic of wnt3a is the capacity to activate both the canonical and noncanonical pathway 21,44 which might partly help explain the contradictory reporting on wnt3a effects. This theory is supported by studies reporting that downregulation of canonical signaling by e.g., dickkopf-related protein 1 (DKK1) as LRP antagonist, is able to partly rescue wnt3ainduced loss of chondrogenesis.…”

MiR-629-3p-induced downregulation of SFTPC promotes cell proliferation and predicts poor survival in lung adenocarcinoma

“…Furthermore, recent evidence also showed that SFTPD could suppress the progression of pancreatic cancer by inducing epithelial-mesenchymal-transition (EMT) and apoptosis of pancreatic cancer cells [16,17]. In addition, it has also been suggested that SFTPA and SFTPB might function as tumour suppressor genes and their dysregulation were closely related to poor prognosis of lung cancer patients [18][19][20][21]. As for SFTPC, one previous study reported that SFTPC deletion was observed in NSCLC tissues, implying that SFTPC downregulation might be involved in the progression of lung cancer [22].…”